Expertise in
2
conditions

Xian H. Wang

Building 11, Chashan Street, 
Wenzhou, CN 
Expertise in
2
conditions
Building 11, Chashan Street, 
Wenzhou, CN 

Overview

Xian Wang practices practicing medicine in Wenzhou, China.

Mr. Wang is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Stomach Cancer, Colorectal Cancer, and Agranulocytosis.

He is actively involved in clinical research, co-authoring 180 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Building 11, Chashan Street, Wenzhou, 325035, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3
A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies
A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Drug: Afuresertib
Study Phase: Phase 3
A Multicenter, Open-label, Exploratory Phase II Clinical Study to Evaluate the Safety and Tolerability and Preliminary Efficacy of TJ107 Combine With Pembrolizumab Injection in Patients With Locally Advanced or Metastatic Solid Tumors
A Multicenter, Open-label, Exploratory Phase II Clinical Study to Evaluate the Safety and Tolerability and Preliminary Efficacy of TJ107 Combine With Pembrolizumab Injection in Patients With Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Unknown
Publish Date: April 15, 2024
Intervention Type: Biological
Study Drugs: TJ107, Pembrolizumab
Study Phase: Phase 2
View 2 Less Clinical Trials

180 Total Publications

Physically guided discovery of high-performance photocatalytic and photovoltaic heterostructures.
Physically guided discovery of high-performance photocatalytic and photovoltaic heterostructures.
Journal: Nanoscale
Published: May 14, 2026

Frequently Asked Questions about Xian H. Wang

Is Xian H. Wang a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Xian H. Wang is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xian H. Wang participate in research or clinical trials?

Yes. Xian H. Wang has published 180 articles and abstracts on conditions like Breast Cancer. You can view a list of Xian H. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wang's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile